My family and I have been watching post-season baseball, and I think I have to lie down. We've seen so many ads for drugs prescribed to treat plaque psoriasis, Crohn's disease, and ulcerative colitis that I'm sure I've developed a rash, nausea, joint pain and dizziness. Just by watching. iSpot, the TV ad news site, says drug companies bought 895.8 million dollars worth of ads in sports programming last year.
One of neurologist Anelyssa D'Abreu's least favorite tasks is giving her patients a dreaded diagnosis: early-stage Alzheimer's disease. But it's not quite as bad as it used to be. Today when they ask, "Is there anything we can do?" D'Abreu has a new answer: "Perhaps." Unlike a decade ago, when D'Abreu had little to offer her patients with Alzheimer's, there are now drugs that may impede the disease's progression.
Experts have issued a warning to Mounjaro users over attempts to squeeze extra doses of the weight-loss drug out of prescribed syringes. Under weight loss plans set up through pharmacies, people pay for four weekly doses of the drug injected from a Kwickpen, which should be discarded after use, says the drug manufacturer Eli Lilly. However, some users are drawing out leftover liquid inside the pen - intended for priming before each injection - to create a fifth dose, dubbed the golden dose.
